Avinger Inc
NASDAQ:AVGR
Avinger Inc
NASDAQ:AVGR
Price:
3.7199 USD
-3.13%
Market Closed
Updated:
May 17, 2024
P/E
Price to Earnings
Price to Earnings
-0.3
Current
-1.1
Median
24.1
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-0.3
Market Cap
/
5.9m
Net Income
-18.3m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Avinger Inc
NASDAQ:AVGR
|
5.9m USD | -0.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.1B USD | 32.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.1B USD | 71 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.5B USD | 37.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 27.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109B USD | 61.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.2B USD | 55.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59B EUR | 38.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
53.6B USD | 37.9 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.9B USD | 81.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
373.7B CNY | 30.7 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-0.4
2-Years Forward
P/E
-2.5
3-Years Forward
P/E
-4
You don't have any saved screeners yet
